Cubist Systematic Strategies, LLC Silverback Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	N/A	77,162 New	77,162 $0
Q1 2023 May 15, 2023	SELL	N/A	-28,966 Reduced 45.2%	35,114 $0
Q4 2022 Feb 14, 2023	BUY	$0.0 - $6.07 $0 - $388,965	64,080 New	64,080 $0
Q2 2022 Aug 15, 2022	SELL	$2.9 - $4.44 $64,153 - $98,221	-22,122 Reduced 60.97%	14,159 $60,000
Q1 2022 May 16, 2022	SELL	$3.51 - $6.74 $29,108 - $55,894	-8,293 Reduced 18.61%	36,281 $127,000
Q4 2021 Feb 14, 2022	SELL	$6.03 - $11.67 $75,254 - $145,641	-12,480 Reduced 21.87%	44,574 $297,000
Q3 2021 Nov 15, 2021	BUY	$9.98 - $35.22 $568,670 - $2.01 Million	56,981 Added 78056.16%	57,054 $569,000
Q2 2021 Aug 16, 2021	BUY	$24.71 - $44.28 $1,803 - $3,232	73 New	73 $2,000

163

62.7M

872K

589K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.